Following the 100% success of Israel’s Alpha TAU’s last clinical trial of Alpha DaRT on recurring skin cancer (see here previously) medical institutes around the world are clamoring to participate in the upcoming pivotal trials. Alpha TAU has also begun … Continue reading →

A small trial of Alpha DaRT from Israel’s Alpha Tau (see here previously) was 100% successful in treating 10 patients with skin cancer. All were 100% clear at 12 weeks with no recurrence or toxicities in 24 weeks. https://www.globenewswire.com/news-release/2023/05/11/2667240/0/en/Alpha-Tau-Announces-the-Publication-of-its-US-Multicenter-Pilot-Skin-Cancer-Trial-Results-in-JAMA-Network-Open.html https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784